Imagion Biosystems Successfully Completes Toxicology Study

May 23, 2019
|In News, Investor updates
|By Matthew

Imagion Biosystems has achieved a key milestone in its progress to first-in-human testing with the successful completion of a toxicology safety study of its lead MagSense® nanoparticle formulation for the detection of HER2 metastatic breast cancer.
Read the announcement.